Clyde Biosciences

United Kingdom
  • Booth: 1739

Clyde Biosciences Ltd uses its proprietary CellOPTIQ system to support early stage drug discovery development. We provide, high-throughput information on the effect of new drug candidates on cardiac ion channels from adult cells and stem cells using optical imaging techniques that detect true transmembrane action potential characteristics such as rate of rise, apd duration, apd shape and calcium transients simultaneously from 96-well plates.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".